LOKAVANT — 2015575
Application number
2015575
Registration number
TMA1301259
International Registration Number
1518519
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2019-12-18
International Registration
2019-12-18
Registered
2025-03-26
Registration Expiry Date
2029-12-18
Registered Owner
Lokavant, Inc.
151 West 42nd Street, 14th Floor
New York New York 10036
UNITED STATES OF AMERICA
Agent
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREET
OTTAWA
ONTARIO K1P1C3
Old Owner
Roivant Sciences GmbH
Viaduktstrasse 8
CH-4051 Basel
SWITZERLAND
Documents
Index headings
- LOKAVANT
- LOKA VANT
Goods (Nice class & Statement)
- 9
- (1) Computers; computer hardware and software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; computer software for providing, analyzing and preparing reports in the fields of health care, namely, medicine and general health and wellbeing, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; computer software for data processing in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; computer software and applications for capturing, collecting, converting, analyzing, communicating, processing, receiving, recording, storing and transmitting data, images and information in the fields of health care, namely, medicine and general health and well-being, and pharmaceutical and biomedical research and development, for use in predictive enrollment forecasting, automated reporting, risk identification, and performance, benchmarking, administration and management of clinical trials and post-market trials; computer software and applications for the integration of artificial intelligence and machine learning in the fields of health care, namely, medicine and general health and well-being, and pharmaceutical and biomedical research and development, for use in predictive enrollment forecasting, automated reporting, risk identification, performance, benchmarking, administration and management of clinical trials and post-market trials; database integration software; software for creating searchable databases for information and data; software for analytics in the fields of public health and health care, namely, medicine and general health and well-being, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software for accessing and using databases in the fields of pharmaceuticals, biomedical research, clinical trial data, post marketing authorization research and post commercial drug research data, all for use in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trials and post-market trials; downloadable software for search engines for compiling, obtaining and making available up-to-date scientific, medicinal, pharmaceutical, biomedical and clinical information as well as for obtaining and making available news of general interest in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; software for managing and analyzing the work procedure in clinical trials and clinical research; software for collecting and managing data in the field of biomedical research; software for biomedical and clinical research services in the fields of health care, namely medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; database management software for biomedical, clinical and medical research.
Services (Nice class & Statement)
- 35
- (1) Advertising and business management consultancy; business management services; business administration; secretarial services; business research in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; business information management; market research; provision of market research information; data processing services in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; business data analysis services, namely, compilation and analysis of Big data in the fields of health care, namely, medicine and general health and well-being, and pharmaceutical and biomedical research and development, for use in predictive enrollment forecasting, automated reporting, risk identification, performance, benchmarking, administration and management of clinical trials and post-market trials; analysis, documentation and professional consultancy services relating to statistics for pharmaceutical and biomedical research, based on artificial intelligence and machine learning; analysis of business cases and statistical analysis in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; systematization and compilation of data in computer databases, in particular compilation of information in computer databases for research and analysis in the fields of public health, health care, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, data from clinical trials, data from post-marketing authorization research for medicinal products and post-commercial launch of medicinal products; business management analysis, professional business consultancy and statistical analysis in the fields of public health, and health care, namely, medicine and general health and well-being, pharmaceuticals, biomedicine, epidemiological research, pharmacoepidemiological research, and for clinical trial and post-market trial data; artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research for business purposes; Strategic business analysis and statistical analysis in the fields of health care, namely medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data;
- 42
- (2) Scientific and technological services as well as research and design services relating thereto, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computers, namely, computer modeling services in the fields of health care, namely, medicine and general health and well-being, and pharmaceutical and biomedical research and development, for use in predictive enrollment forecasting, automated reporting, risk identification, performance, benchmarking, administration and management of clinical trials and post-market trials; pharmaceutical, biomedical, biological-therapeutic research services; research in the field of pharmaceutical and biological-therapeutic products; pharmaceutical and biopharmaceutical research and development; providing information relating to scientific research in the field of pharmaceuticals, biomedicine, clinical trials and post-marketing authorization research for medicinal products and commercial post-marketing launch of medicinal products; cloud computing providing software for database management; cloud computing featuring software for monitoring, compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news of general interest in the fields of health care, namely medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; cloud computing featuring software for conducting scientific research and analysis in the fields of health care, namely medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; cloud computing featuring software for providing, analyzing and generating reports, for data processing, for the monitoring, capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information, for the conversion, analysis, processing, storage and transmission of artificial intelligence, for database integration, for creating searchable databases of information and data, for analytics, for managing and analyzing clinical trial and clinical research workflow, for use in collecting and managing data in the field of biomedical research, for biomedical and clinical research services, and database management software, all of the foregoing in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; Providing temporary use of non-downloadable software for accessing databases in connection with research and development services in the fields of health care, namely, medicine and general health and well-being, pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, and for clinical trials and post-market trials; temporary online provision of non-downloadable software for research in the field of pharmaceuticals and biopharmaceuticals; temporary online provision of non-downloadable software for compilation, obtaining, monitoring, management and provision of up-to-date scientific, pharmaceutical, medicinal and clinical information as well as news of general interest in the fields of health care, namely, medicine and general health and well-being, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; temporary provision of non-downloadable software applications accessible through a website for data analysis, financial analysis and risk management for use in the fields of pharmaceutical research and development and biomedical, clinical trials and of health care, namely medicine and general health and well-being; software services from an application service provider (ASP) providing software for the collection, processing, storage, retrieval, analysis and transmission of clinical trial and post-market trial data.
Claims
- Date de priorité de production: 28 juin 2019, pays ou bureau: SUISSE, demande no. 740044 en liaison avec le même genre de produits et en liaison avec les services
Recordals (known also as Footnotes)
Change of Ownership of International Registration / Changement de titulaire de l'enregistrement international DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-09-13 DATE OF CHANGE / DATE DE CHANGEMENT: 2023-08-10 COMMENTS / COMMENTAIRES: From: Roivant Sciences GmbH To: Lokavant, Inc.Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2019-12-18 | Registration | |
| International Registration | 2019-12-18 | 2029-12-18 | |
| Created | 2020-03-04 | ||
| Formalized | 2020-03-04 | ||
| Designation Notification - Madrid Protocol | 2020-03-05 | 2021-09-05 | |
| Notification of Possible Opposition Sent | 2021-01-05 | ||
| Search Recorded | 2021-07-14 | ||
| Examiner's First Report | 2021-07-14 | 2022-01-14 | |
| Total Provisional Refusal | 2021-07-14 | 2022-01-14 | |
| Agent Changed | 2022-02-18 | From: To: 8390 / Voir Preuve au dossier/See evidence on File No. 2015575 | |
| Note to file | 2023-03-29 | PA/PR Language changed from French to English | |
| Correspondence Created | 2023-03-29 | 2023-09-29 | |
| Change of Title Registered | 2023-09-14 | DP:2023-09-13 Effective Date: 2023-08-10 | |
| Agent Changed | 2023-09-28 | From/De: To/A: 8390 | |
| Extension of Time | 2023-10-04 | 2024-03-29 | Request Letter Date: 2023/09/28 |
| Approved | 2024-12-10 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2024-12-10 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-01-08 | Vol.72 Issue 3663 | |
| Opposition Start Date Notice Sent | 2025-01-08 | Requested on 2025/01/08 00:30:05 in program jr500m1 | |
| Registration Pending | 2025-03-26 | ||
| Registered | 2025-03-26 | ||
| Statement of Grant of Protection Sent (following a Provisional Refusal) | 2025-03-26 |